2m 2m 2m 2m 2m 2m 2m
NEUMORA (NMRA)
NASDAQ
$0.45-$0.02 (-3.34%)
Price as of Nov 11, 2026 7:50 PM EST- $87.7MMarket Cap
- -83.03%1-Year Change
- BiotechnologyIndustry
NEUMORA (NMRA)
$0.45-$0.02 (-3.34%)
NMRA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.47 | ||
Change | -$0.02 (-3.97%) | ||
Open | $0.48 | ||
High | $0.49 | ||
Low | $0.45 | ||
Previous Close | $0.49 | ||
Volume | 752,590 | ||
30-Day Average Volume | 2,048,980 | ||
1-Week Change | -18.27% | ||
1-Month Change | -1.91% | ||
1-Year Change | -83.03% | ||
3-Year Change | -95.97% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 187.9M | ||
Total Assets | $125.2M | ||
Market Cap | $87.7M | ||
Enterprise Value | $83.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$43.1M | ||
Free Cash Flow | -$39.5M | ||
EBIT | -$41.7M | ||
EBITDA | -$41.6M | ||
Net Working Capital | $97.1M | ||
EPS | -$0.23 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue